Equity Overview
Price & Market Data
Price: $11.51
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $2,604,064,768
Daily Volume: 0
Performance Metrics
1 Week: 17.62%
1 Month: 17.62%
3 Months: 17.62%
6 Months: 27.78%
1 Year: 25.37%
YTD: 30.54%
Company Details
Employees: 2026
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immunostimulants; metabolism; and systematic hormonal preparations. It has a multi-target partnership with Etherna to research and develop mRNA-based therapies for medical dermatology. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.